Congress Materials

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Lu S, Zhou Q, Liu X, Du Y, Fan Y, Cheng Y, Fang J, Lu Y, Huang C, Zhou J, Song Y, Wang K, Pan H, Yang N, Li J, Chen G, Chang J, Cui J, Liu Z, Bai C, Zhang H, Thurm H, Peltz G, Li H, Zhao H, Wu Y-L September 8, 2021 WCLC 2021 Lung Cancer

Lorlatinib for Previously-Treated ALK-positive Advanced Non-Small Cell Lung Cancer: Primary Efficacy and Safety Data from a Phase 2 Study in China

View Presentation
Poster
Gregory J, Kilvert H, Williams T, Cooper M, Polli A, Iadeluca L, Ou SHI September 8, 2021 WCLC 2021 Lung Cancer

Lorlatinib in First Line Treatment of Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Network Meta-analysis

View Presentation
Poster
Wu Y-L, Lu S, Yang JC-H, Zhou J, Seto T, Ahn M-J, Su W-C, Yamamoto N, Kim D-W, Paolini J, Usari T, Wilner KD, Goto K September 8, 2021 WCLC 2021 Lung Cancer

Overall Survival from a Phase 2 Study of Crizotinib in East Asian Patients With ROS1+ Advanced Non-Small-Cell Lung Cancer

View Presentation
Poster
Takahashi T, Nishio M, Yatabe Y, Nishino K, Yoshiki Y, Shiraiwa N, Emir B, Iadeluca L, Nishio K September 8, 2021 WCLC 2021 Lung Cancer

Real-world data of NGS diagnostic biomarker testing for lung cancer patients in Japan

View Presentation
Poster
Goto Y, Emir B, Kaneyasu K, Kikkawa H, Wiltshire R, Shukuya T September 8, 2021 WCLC 2021 Lung Cancer

Therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive NSCLC in real-world

View Presentation